Wrap up: Loyal announces latest achievement in FDA approval process, and other news

Happy Friday dvm360 readers! Who is ready for VMX? The dvm360 editorial team is! Throughout the show, our editors will be providing you with interviews from speakers who will provide more insight into their lectures, articles covering a wide range of topics from social media safety to a complete approach to antimicrobial therapy in dermatology, not to mention the keynote address, which will be given by John Travolta. There is so much that will be coming out on dvm360.com during the show, so be sure to check in!

Now that we are wrapping up another week, here is some news from this week:

• Loyal recently announced a major milestone in its journey to receive FDA approval, it has had its target animal safety technical section accepted by the federal agency. Read more about what this means for the approval process here.
• dvm360 student ambassador Diana Caro recently contributed an article where she discussed how she faced academic dismissal from a veterinary school and how with the help of her support system, she picked herself back up and persevered.
• Are virtual assistants helpful or over hyped in the veterinary industry? On this week’s episode of The Vet Blast Podcast presented by dvm360, host Adam Christman, DVM, MBA, and Kelly Cronin, MBA, BS, CVT, PHR, VTS (ECC), VSPN, set out to inform listeners just how helpful these tools can be.
• Pet Poison Helpline recently shared their Top 10 pet poisons in 2025; a list they share every year to highlight the most frequently reported toxins that are called into their call center for North America. Check out the top 10 here.
• In this recent video interview with dvm360, Christoher Pachel, DVM, DACVB, CABC, shared what the clinical decision process can look like for treating a canine with separation anxiety.
• Investigators at Louisiana State University were recently rewarded a grant to explore detection of equine herpesvirus, with the goal of determining where in the body the virus resides during latency, following a 2025 outbreak of the disease in the US.
• And more!